| Literature DB >> 33391432 |
Caoli Tang1, Duanya Liu1, Yongsheng Fan1, Jun Yu1, Cong Li1, Jianmei Su1,2, Chunhong Wang1.
Abstract
Cyclic adenosine monophosphate (cAMP) is an essential second messenger that widely distributed among prokaryotic and eukaryotic organisms. cAMP can regulate various biological processes, including cell proliferation, differentiation, apoptosis and immune functions. Any dysregulation or alteration of cAMP signaling may cause cell metabolic disorder, immune dysfunction and lead to disease or cancer. This study aimed to conduct a scientometric analysis of cAMP signaling system in cancer field, and explored the research trend, hotspots and frontiers from the past decade. Relevant literatures published from 2009 to 2019 were collected in the Web of Science Core Collection database. EndNote X9 was used to remove duplicate articles, and irrelevant articles were manually filtered. Bibliometric analyses were completed by CiteSpace V. A total of 4306 articles were included in this study. The number of related literatures published each year is gradually increasing. Most of them belong to "Biochemistry & Molecular Biology", "Oncology", "Cell Biology", "Pharmacology & Pharmacy" and "Endocrinology & Metabolism" areas. In the past decade, USA, China, and Japan contributed the most to the research of cAMP signaling system in cancer. The frontiers and hotspots of cAMP signaling pathway system related to cancer fields mainly focused on cancer cell apoptosis, metastasis, and multiple tumors occurrence in patients with Carney complex. Intervention of the cAMP metabolic pathway may be a potential and promising therapeutic strategy for controlling clinical cancer and tumor diseases. © The author(s).Entities:
Keywords: Bibliometrics; Cancer; CiteSpace; Hotspots; cAMP
Year: 2021 PMID: 33391432 PMCID: PMC7738981 DOI: 10.7150/jca.47158
Source DB: PubMed Journal: J Cancer ISSN: 1837-9664 Impact factor: 4.207
Top ten categories of cAMP signaling system with its linkage to cancer from 2009 to 2019
| Rank | Category | Count | Category | Centrality |
|---|---|---|---|---|
| 1 | Biochemistry & Molecular Biology | 997 | Pharmacology & Pharmacy | 0.27 |
| 2 | Oncology | 826 | Biochemistry & Molecular Biology | 0.25 |
| 3 | Cell Biology | 823 | Immunology | 0.23 |
| 4 | Pharmacology & Pharmacy | 481 | Biotechnology & Applied Microbiology | 0.16 |
| 5 | Endocrinology & Metabolism | 478 | Chemistry | 0.15 |
| 6 | Science & Technology - Other Topics | 378 | Neurosciences & Neurology | 0.14 |
| 7 | Multidisciplinary Sciences | 359 | Physiology | 0.14 |
| 8 | Medicine, Research & Experimental | 264 | Toxicology | 0.14 |
| 9 | Neurosciences & Neurology | 254 | Cell Biology | 0.11 |
| 10 | Chemistry | 214 | Hematology | 0.10 |
Top ten institutions contributed to publications on cAMP signaling system with its linkage to cancer from 2009 to 2019
| Rank | Count | Institution | Country |
|---|---|---|---|
| 1 | 65 | Chinese Acad Sci | China |
| 2 | 60 | Shanghai Jiao Tong Univ | China |
| 3 | 56 | Univ Texas MD Anderson Canc Ctr | USA |
| 4 | 54 | Seoul Natl Univ | South Korea |
| 5 | 49 | Univ Calif San Diego | USA |
| 6 | 46 | NCI | USA |
| 7 | 45 | Univ Calif Los Angeles | USA |
| 8 | 44 | China Med Univ | China |
| 9 | 39 | Peking Univ | China |
| 10 | 39 | Eunice Kennedy Shriver Natl Inst Child Hlth & Hum | USA |
Top ten journals contributed to publications on cAMP signaling system in cancer field from 2009 to 2019
| Rank | Citation | Cited Journal | IF (2018) | Journal Citation Reports (JCR) | Country |
|---|---|---|---|---|---|
| 1 | 3112 | Journal of Biological Chemistry | 4.106 | Q2 | USA |
| 2 | 2680 | Proceedings of the National Academy of Sciences of the United States of America | 9.580 | Q1 | USA |
| 3 | 2086 | Nature | 43.070 | Q1 | England |
| 4 | 2047 | Cancer Research | 8.378 | Q1 | USA |
| 5 | 1785 | Science | 41.037 | Q1 | USA |
| 6 | 1688 | Cell | 36.216 | Q1 | USA |
| 7 | 1511 | Oncogene | 6.634 | Q1 | England |
| 8 | 1416 | Plos One | 2.776 | Q3 | USA |
| 9 | 1314 | Molecular and Cellular Biology | 2.705 | Q2 | USA |
| 10 | 1307 | Biochemical and Biophysical Research Communications | 3.735 | Q3 | USA |
The top ten active authors and co-cited authors contributed to publications on cAMP signaling system in cancer field from 2009 to 2019
| Rank | Top 10 productive author | Top 10 co-cited author | ||||
|---|---|---|---|---|---|---|
| Author | Country | Count | Co-cited author | Country | Citation | |
| 1 | Stratakis CA | USA | 46 | Livak KJ | USA | 166 |
| 2 | Bertherat J | France | 21 | Mayr B | USA | 149 |
| 3 | Nesterova M | France | 11 | Kirschner LS | USA | 114 |
| 4 | Horvath A | France | 11 | Wang Y | USA | 110 |
| 5 | Zhang W | China | 10 | Shaywitz AJ | USA | 99 |
| 6 | Schuller HM | USA | 10 | Li Y | USA | 94 |
| 7 | Al-Wadei HA | USA | 9 | Jemal A | USA | 91 |
| 8 | Stocco DM | USA | 9 | Zhang Y | China | 85 |
| 9 | Rubin JB | USA | 9 | Stocco DM | USA | 82 |
| 10 | Kawabata T | Japan | 8 | Taylor SS | USA | 75 |
The top 20 keywords
| Rank | Frequency | Keywords | Centrality |
|---|---|---|---|
| 1 | 977 | expression | 0.12 |
| 2 | 761 | cAMP | 0.09 |
| 3 | 650 | activation | 0.07 |
| 4 | 514 | cancer | 0.07 |
| 5 | 482 | gene expression | 0.14 |
| 6 | 420 | phosphorylation | 0.03 |
| 7 | 400 | apoptosis | 0.13 |
| 8 | 368 | cell | 0.04 |
| 9 | 354 | protein kinase a | 0.12 |
| 10 | 334 | proliferation | 0.08 |
| 11 | 328 | growth | 0.03 |
| 12 | 320 | pathway | 0.04 |
| 13 | 299 | 0.06 | |
| 14 | 294 | protein | 0.04 |
| 15 | 290 | breast cancer | 0.05 |
| 16 | 274 | receptor | 0.02 |
| 17 | 252 | inhibition | 0.02 |
| 18 | 242 | gene | 0.07 |
| 19 | 233 | cancer cell | 0.06 |
| 20 | 222 | CREB | 0.08 |
The basic information of ten clusters
| Cluster ID | Terms | Size | S value | Mean (Year) |
|---|---|---|---|---|
| 0 | naphthol AS-E | 59 | 0.886 | 2008 |
| 1 | exchange protein | 55 | 0.845 | 2012 |
| 2 | proton-sensing GPCR | 43 | 0.847 | 2012 |
| 3 | protein kinase | 43 | 0.858 | 2007 |
| 4 | carney complex | 36 | 0.940 | 2007 |
| 5 | PKA enhancement | 36 | 0.935 | 2007 |
| 6 | inhibitory neurotransmitter | 34 | 0.885 | 2008 |
| 7 | somatic mutation | 34 | 0.904 | 2012 |
| 8 | fibrolamellar carcinoma | 32 | 0.966 | 2014 |
| 9 | pharmacological target | 30 | 0.968 | 2010 |
| 10 | selective indoleamine-2 | 26 | 0.984 | 2013 |
| 11 | MAPK phosphatase-1 | 17 | 0.963 | 2007 |
| 12 | mouse skin papilloma development | 16 | 0.937 | 2005 |
| 13 | dosage-sensitive sex reversal | 16 | 0.991 | 2004 |
| 14 | unfavorable postoperative survival | 12 | 0.994 | 2008 |
| 15 | protein-coupled estrogen receptor | 8 | 0.982 | 2007 |